Alcon Inc.
Healthcare · EUR · XETRA
Price
€56.62
Cap
€30.51B
Earnings
—
30d Trend
-11.6%
32% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 48×Macro 0.99 (−1%)=48
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
Limited short-term thesis
BRAIN47'S ASSESSMENT
I rate Alcon Inc. at 48/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is quality at 56/100. I classify this as a income position with the strongest thesis on a short-term horizon.
PAST PERFORMANCE
1 MONTH
-9.3%
3 MONTHS
-22.7%
12 MONTHS
-24.9%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Limited short-term thesis. Quality (56) and Fundamentals (56) are the primary strengths. I note that momentum is the weakest area at 34/100 — this warrants monitoring. Historical volatility is moderate at 32%. I classify this as an income position — the 2.8% yield combined with the dividend profile makes it suitable for income generation.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.